Skip to content

IPEX INFLECTION POINT ACQU CORP V

Follow

ORD SHS CL A (common), issuer CIK 2028355

Filings received so far for Q3 2026: 0 13F filers report a position in IPEX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource

Events

  • GLAZER CAPITAL, LLC and 1 other reporting person reported 0 IPEX shares, 0% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001076809-26-000164

    Accepted , ingested
  • MIZUHO FINANCIAL GROUP INC reported 0 IPEX shares, 0% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-12. 0001104659-26-125822

    Accepted , ingested
  • BERKLEY W R CORP and 1 other reporting person reported 0 IPEX shares, 0% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-09. 0001628280-26-072398

    Accepted , ingested
  • Inflection Point Fund I, LP and 2 other reporting persons reported 0 IPEX shares, 0% of the class, as of 2026-09-24, in a 13D/A filed 2026-09-25. 0001213900-26-103567

    Accepted , ingested